Therapeutic Area | MeSH |
---|---|
neoplasms | D009369 |
signs and symptoms pathological conditions | D013568 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Stomach neoplasms | D013274 | EFO_0003897 | C16 | — | 2 | 1 | — | — | 3 |
Carcinoma | D002277 | — | C80.0 | — | — | 1 | — | — | 1 |
Neoplasms | D009369 | — | C80 | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Ovarian neoplasms | D010051 | EFO_0003893 | C56 | — | 4 | — | — | — | 4 |
Peritoneal neoplasms | D010534 | — | — | — | 3 | — | — | — | 3 |
Adenocarcinoma | D000230 | — | — | — | 2 | — | — | — | 2 |
Urinary bladder neoplasms | D001749 | — | C67 | 2 | 1 | — | — | — | 2 |
Ovarian epithelial carcinoma | D000077216 | — | — | — | 2 | — | — | — | 2 |
Fallopian tube neoplasms | D005185 | — | — | — | 1 | — | — | — | 1 |
Ascites | D001201 | HP_0001541 | R18 | — | 1 | — | — | — | 1 |
Drug common name | Catumaxomab |
INN | catumaxomab |
Description | Catumaxomab (rat/mouse hybrid 3funct) |
Classification | Antibody |
Drug class | monoclonal antibodies |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL2108581 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | DB06607 |
UNII ID | M2HPV837HO (ChemIDplus, GSRS) |